Corporate Overview   Customer Profiles   Mission & Values   Careers

Cardiocom develops, manufactures, and markets the entire Telemonitoring System, assuring you the highest quality, lowest cost products and services

Cardiocom is a world-class, experienced provider of remote telemonitoring systems.

Founded in 1997 by Louis C. Cosentino, Ph.D., Cardiocom addresses the needs of chronically ill patients and reduces medical costs by combining leading edge, vital sign telemonitoring with personal nursing services. The founders of the company have more than 75 medical device patents and more than 65 years of combined experience in the fields of medical technology, development, manufacturing and marketing. Our strong investment in new technologies means that our customers will benefit from unique features not found in other remote monitoring systems.

Cardiocom is the only fully vertically integrated company offering beginning-to-end services from a single site. Clients benefit from our tightly integrated disease management programs, hardware and software product design, testing, manufacturing, nurse call center services, outcomes study design, reporting and customer support. This vertical integration ensures our customers the highest quality, custom telehealth solutions at the lowest cost.

Cardiocom is in its fourth generation of internally developed remote monitoring devices. Cardiocom is the direct manufacturer and not just an "assembler" of third party components. The Company designs and manufactures its own telehealth system, medical weight scale, blood pressure measurement device and blood glucose management system.

In 2006, Cardiocom announced the development of the GlucoCom® System, a blood glucose meter with a telemonitoring system for diabetes management. No other company offers a similar product for low-cost daily blood glucose monitoring with trended reporting. Cardiocom's investment in new, patented technologies means that our customers benefit from unique features not found in other telehealth systems.

Cardiocom compliments these new technology offerings with a sound disease management program using evidence based medicine and clinical practice guidelines from the American Diabetes Association, American Heart Association and other pertinent professional societies or quality of care organizations. Cardiocom will customize its clinical program to meet any guidelines or content required by our customers.

Cardiocom's unique products and methods are supported by issued U.S. and foreign patents with continuations and new applications.

• U.S. Patent No. 6,454,705 Medical wellness parameters management system,
  apparatus and method.
• U.S. Patent No. 6,290,646 Apparatus and method for monitoring and communicating
  wellness parameters of ambulatory patients.
• U.S. Patent No. 6,755,783 Apparatus and method for two-way communication in a device
  for monitoring and communicating wellness parameters of ambulatory patients.
• U.S. Patent No. 6,723,045 Apparatus and method for monitoring and communicating
  wellness parameters of ambulatory patients.
• U.S. Patent No. 7,577,475 System, method, and apparatus for combining information from an implanted device with information from a patient monitoring apparatus.